3M Pharmaceuticals has ceased production of Medihaler® Ergotamine (ergotamine tartrate) due to unresolved problems with the raw materials that make up this drug. Continue Reading
Ergomar® is a medication containing 2mg of ergotamine tartrate to be taken sublingually. Unlike other formulations of ergotamine, Ergomar® does not contain caffeine. Because success in aborting migraines is dependent on rapidity of treatment, one sublingual tablet should be placed under the tongue at the first sign of an attack. Another should be placed under the tongue at half-hourly intervals if necessary for a total of three tablets (6mg total) in any 24-hour period. No more than five tablets should be taken in one week.
This medicine can cause rebound headaches and, therefore, should not be used more than 2 days per week.
Ergostat®, a similar sublingual medication, is no longer available. Some special pharmacies may be able to compound this medication at the request of your physician.